ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 59 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,800,000 | +61.9% | 4,000,000 | 0.0% | 0.53% | +75.2% |
| Q2 2023 | $4,200,000 | +2.9% | 4,000,000 | +17.6% | 0.30% | -0.7% |
| Q1 2023 | $4,080,000 | -9.3% | 3,400,000 | +13.3% | 0.30% | -20.2% |
| Q4 2022 | $4,500,001 | -57.6% | 3,000,000 | -11.5% | 0.38% | -53.5% |
| Q3 2022 | $10,610,000 | -10.2% | 3,390,000 | -5.9% | 0.82% | -1.8% |
| Q2 2022 | $11,820,000 | +10.3% | 3,603,637 | +53.3% | 0.84% | +45.5% |
| Q1 2022 | $10,716,000 | +138.1% | 2,350,000 | +279.0% | 0.57% | +245.8% |
| Q4 2021 | $4,501,000 | – | 620,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
| Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
| 683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
| Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
| MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
| Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
| Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
| Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |